Xiaomi, a volunteer in phase 1 of human clinical trials of the COVID-19 vaccine, recently shared her experience on her own Weibo account.
She was one of the first volunteers to participate in human trials.
The purpose of the trial is to test and evaluate the safety and efficacy of recombinant new coronavirus vaccines (adenovirus vectors).
Phase 1 is limited to volunteers living in the Wuchang, Hongshan and Donghu districts of Wuhan and aged between 18-60 years old.
Patients are then asked to isolate for 14 days while medical experts observe the effectiveness of the vaccine.
Isolation meal
Within six months of vaccination, the medical team will be regularly checking in on the volunteers to measure any side effects and to confirm whether injected patients will have been producing anti-s protein-specific antibodies.
With such antibodies, the immune system is ready to keep the virus out of the cell.
Haifeng is another patient who was part of the same batch of volunteers as Xiaomi. He said he was the oldest volunteer that day. "To be able to give the country and society a little help, play a small part this is living life without regret."
According to academician Wang Junzhi, vaccines are still being produced based on five major technical approaches, some of which have already been tested on animals.
Most research medical teams are aiming to complete their preclinical studies before their targeted deadline in April and start human trials gradually.
Click: COVID-19 Vaccines to Start Clinical Trials in April, Experts Say
Source: weibo
\n
Comments
Post a Comment